![5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone](https://static.cymitquimica.com/products/3D/img/XJB57393.png "Clique para ampliar")
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
CAS: 872573-93-8
Ref. 3D-XJB57393
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado |
Informação sobre produto
Nome:
5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
Sinónimos:
- Ro-3306
- (5Z)-5-(quinolin-6-ylmethylidene)-2-(thiophen-2-ylmethylamino)-1,3-thiazol-4-one
- 5-(6-Quinolinylmethylene)-2-[(2-thienylmethyl)amino]-4(5H)-thiazolone
- (Z)-5-(quinolin-6-ylmethylene)-2-(thiophen-2-ylmethylamino)thiazol-4(5H)-one
- 2-[[(Thiophen-2-yl)methyl]amino]-5-[1-(quinolin-6-yl)meth-(Z)-ylidene]thiazol-4-one
- (5Z)-5-Quinolin-6-ylmethylene-2-[(thiophen-2-ylmethyl)-amino]-thiazol-4-one
Descrição:
Quizartinib is a targeted inhibitor of the protein kinase A-Raf signaling pathway and is used for the treatment of certain types of cancer. Quizartinib inhibits the polymerase chain reaction, which can lead to cell death. It also has inhibitory properties on some cancer cells by targeting her2+ breast cancer cells and inhibiting tumor growth in vivo models. Quizartinib has been shown to be effective against autoimmune diseases such as lupus erythematosus, rheumatoid arthritis, and psoriasis. This drug also exhibits pluripotency markers that are similar to those found in embryonic stem cells.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
351.45 g/mol
Fórmula:
C18H13N3OS2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
